{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:41:46Z","timestamp":1789717306434,"version":"4.0.1"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf01052723","type":"journal-article","created":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T13:00:57Z","timestamp":1107176457000},"page":"121-139","source":"Crossref","is-referenced-by-count":96,"title":["A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors"],"prefix":"10.1007","volume":"20","author":[{"given":"David J.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-94-009-3347-7_71","volume-title":"Brain Oncology, Biology, Diagnosis, and Therapy","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ: Human central nervous system pharmacology of antineoplastic agents: implications for the treatment of brain tumors. In: Chatel M, Darcel F, Pecker J (eds)Brain Oncology, Biology, Diagnosis, and Therapy, Martinus Nijhoff Publishers, Dordrecht, 1987, pp 387?395"},{"key":"CR2","first-page":"57","volume":"2","author":"VA Levin","year":"1975","unstructured":"Levin VA: A pharmacologic basis for brain tumor chemotherapy. Sem Oncol 2: 57?61, 1975","journal-title":"Sem Oncol"},{"key":"CR3","first-page":"149","volume":"1","author":"U Boghdan","year":"1983","unstructured":"Boghdan U: Chemosensitivity of malignant brain tumors: preliminary results. J Neuro-Oncol 1: 149?166, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR4","first-page":"70","volume":"13","author":"RG Blasberg","year":"1986","unstructured":"Blasberg RG, Groothuis DR: Chemotherapy of brain tumors: physiological and pharmacokinetic considerations. Semin Oncol 13: 70?82, 1986","journal-title":"Semin Oncol"},{"key":"CR5","first-page":"1232","volume":"37","author":"Y Ushio","year":"1977","unstructured":"Ushio Y, Posner J, Shapiro W: Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 37: 1232?1237, 1977","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00150615","volume":"4","author":"T Siegal","year":"1987","unstructured":"Siegal T, Sandbank U, Gabizon A, Siegal T, Mizrachi R, Ben-David E, Catane R: Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. J Neuro-Oncol 4: 233?242, 1987","journal-title":"J Neuro-Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archneur.1977.00500210025002","volume":"34","author":"NA Vick","year":"1977","unstructured":"Vick NA, Khandekar JD, Bigner DD: Chemotherapy of brain tumors. The ?blood-brain barrier? is not a factor. Arch Neurol 34: 523?526, 1977","journal-title":"Arch Neurol"},{"issue":"Suppl 2","key":"CR8","first-page":"13","volume":"65","author":"DR Groothuis","year":"1981","unstructured":"Groothuis DR, Fischer JM, Vick NA, Bigner DD: Comparative permeability of different glioma models to horseradish peroxidase. Cancer Treat Rep 65 (Suppl 2): 13?18, 1981","journal-title":"Cancer Treat Rep"},{"key":"CR9","first-page":"3058","volume":"36","author":"CH Tator","year":"1976","unstructured":"Tator CH: Retention of tritiated methotrexate in a transplantable mouse glioma. Cancer Res 36: 3058?3066, 1976","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00153636","volume":"1","author":"N Savaraj","year":"1983","unstructured":"Savaraj N, Lu K, Feun LG, Leavens ME, Stewart DJ, Burgess MA, Benjamin RS, Loo TL: Intracerebral penetration and tissue distribution of 2,5-Diaziridinyl 3,6-bis(Carboethoxyamino) 1,4-Benzoquinone, (AZQ NSC 182986). J Neuro-Oncol 1: 15?20, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00163544","volume":"6","author":"RM Green","year":"1988","unstructured":"Green RM, Stewart DJ, Hugenholtz H, Richard MT, Thibault M, Montpetit V: Human central nervous system and plasma pharmacology of mitoxantrone. Journal of Neuro-Oncology 6: 75?83, 1988","journal-title":"Journal of Neuro-Oncology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4613-2297-9_57","volume-title":"Biology of Brain Tumor","author":"DJ Stewart","year":"1986","unstructured":"Stewart DJ, Green RM, Hugenholtz H, Richard MT, Dennery J, Montpetit V, Hopkins HS, Thibault M: Human central nervous system pharmacology of tiazofurin. In: Walker MD, Thomas DGT (eds)Biology of Brain Tumor, Martinus Nijhoff Publishers, Boston, 1986, pp 423?427"},{"key":"CR13","first-page":"187","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Leavens M, Lu K, Wang YM, Benjamin RS, Ho DH, Yap HY, Loo TL: Central nervous system pharmacology of Baker's antifolate (NSC 139105) in man. J Neuro-Oncology 2: 187?193, 1984","journal-title":"J Neuro-Oncology"},{"key":"CR14","first-page":"133","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Richard M, Hugenholtz H, Dennery J, Belanger R, Gerin-Lajoie J, Montpetit V, Nundy D, Prior J, Hopkins H: Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors. J Neuro-Oncology 2: 133?139, 1984","journal-title":"J Neuro-Oncology"},{"key":"CR15","first-page":"3163","volume":"40","author":"DJ Stewart","year":"1980","unstructured":"Stewart DJ, Leavens M, Friedman J, Benjamin RS, Moore EC, Bodey GP, Valdivieso M, Burgess MA, Wiseman C, Loo TL: Penetration of N-(phosphoacetyl)-L-aspartate into human central nervous system and intracerebral tumor. Cancer Research 40: 3163?3166, 1980","journal-title":"Cancer Research"},{"key":"CR16","first-page":"1253","volume":"64","author":"KL Fong","year":"1980","unstructured":"Fong KL, Ho DHW, Yap BS, Stewart DJ, Brown NS, Benjamin RS, Freireich EJ, Bodey GP: Clinical pharmacology of IMPY by radio-immunoassay. Cancer Treat Rep 64: 1253?1260, 1980","journal-title":"Cancer Treat Rep"},{"key":"CR17","first-page":"459","volume":"41","author":"M Rosenblum","year":"1981","unstructured":"Rosenblum M, Stewart DJ, Yap BS, Leavens M, Benjamin RS, Loo TL: Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans. Cancer Research 41: 459?462, 1981","journal-title":"Cancer Research"},{"key":"CR18","first-page":"2474","volume":"42","author":"DJ Stewart","year":"1982","unstructured":"Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474?2479, 1982","journal-title":"Cancer Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00165719","volume":"1","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, Benvenuto J, Leavens M, Smith R, Cabanillas F, Benjamin RS, Loo Ti Li: Human central nervous system pharmacology of pentamethylmelamine and its metabolites. J of Neuro-Oncol 1: 357?364, 1983","journal-title":"J of Neuro-Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/bjs.1800561021","volume":"56","author":"D Rowe-Jones","year":"1969","unstructured":"Rowe-Jones D: Cytotoxic penetration and concentration in human malignant tumors. Br J Surg 56: 774?778, 1969","journal-title":"Br J Surg"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/52.4.1327","volume":"52","author":"J Straw","year":"1974","unstructured":"Straw J, Hart M, Klubes P, Zaharko D, Dedrick R: Distribution of anticancer agents in spontaneous animal tumors I. Regional blood flow and methotrexate distribution in canine lymphosarcoma. J Natl Cancer Inst 52: 1327?1331, 1974","journal-title":"J Natl Cancer Inst"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000421-198804000-00013","volume":"11","author":"DJ Stewart","year":"1988","unstructured":"Stewart DJ, Mikheal NZ, Nair RC, Kacew S, Montpetit V, Nanji A, Maroun JA, Howard K: Platinum concentrations in human autopsy tumor samples. American Journal of Clinical Oncology (CCT) 11: 152?158, 1988","journal-title":"American Journal of Clinical Oncology (CCT)"},{"key":"CR23","first-page":"1255","volume":"70","author":"DJ Stewart","year":"1986","unstructured":"Stewart DJ, Green RM, Mikhael NZ, Montpetit V, Thibault M, Maroun JA: Human autopsy tissue concentrations of mitoxantrone. Cancer Treatment Reports 70: 1255?1261, 1986","journal-title":"Cancer Treatment Reports"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archneur.1975.00490540029003","volume":"32","author":"VA Levin","year":"1975","unstructured":"Levin VA, Freeman-Dove W, Landahl HD: Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 32: 785?791, 1975","journal-title":"Arch Neurol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3171\/jns.1987.67.5.0697","volume":"67","author":"PA Stewart","year":"1987","unstructured":"Stewart PA, Hayakawa K, Farrell CL, Del Maestro RF: Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. J Neurosurg 67: 697?705, 1987","journal-title":"J Neurosurg"},{"key":"CR26","first-page":"4478","volume":"50","author":"Y Boucher","year":"1990","unstructured":"Boucher Y, Baxter LT, Jain RK: Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50: 4478?4484, 1990","journal-title":"Cancer Res"},{"key":"CR27","first-page":"2641","volume":"48","author":"RK Jain","year":"1988","unstructured":"Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641?2658, 1988","journal-title":"Cancer Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3171\/jns.1983.58.6.0863","volume":"58","author":"RG Blasberg","year":"1983","unstructured":"Blasberg RG, Molnar P, Horowitz M, Kornblith P, Pleasants R, Fenstermacher J: Regional blood flow in RT-9 brain tumor. J Neurosurg 58: 863?873, 1983","journal-title":"J Neurosurg"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0090-3019(84)90329-X","volume":"21","author":"H Tachibana","year":"1984","unstructured":"Tachibana H, Meyer JS, Rose JE, Kandula P: Local cerebral blood flow and partition coefficients measured in cerebral astrocytomas of different grades of malignancy. Surg Neurol 21: 125?131, 1984","journal-title":"Surg Neurol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.48.4.310","volume":"48","author":"RP Beaney","year":"1985","unstructured":"Beaney RP, Brooks DJ, Leenders KL, Thomas DGT, Jones T, Halnan KE: Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumors as studied by positron emission tomography, with observations on the effect of decompressive surgery. J Neurol Neurosurg Psych 48: 310?319, 1985","journal-title":"J Neurol Neurosurg Psych"},{"key":"CR31","first-page":"2304","volume":"39","author":"MJ Mantyla","year":"1979","unstructured":"Mantyla MJ: Regional blood flow in human tumors. Cancer Res 39: 2304?2306, 1979","journal-title":"Cancer Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3171\/jns.1986.65.2.0233","volume":"65","author":"HR Reichman","year":"1986","unstructured":"Reichman HR, Farrell CL, Del Maestro RF: Effects of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model. J Neurosurg 65: 233?237, 1986","journal-title":"J Neurosurg"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00177352","volume":"8","author":"WR Shapiro","year":"1990","unstructured":"Shapiro WR, Hiesiger EM, Cooney GA, Basler GA, Lipschutz LE, Posner J: Temporal effects of dexamethasone on blood-to-brain and blood-to-tumor transport of14C-alpha-aminoisobutyric acid in rat C6 glioma. J Neuro-Oncol 8: 197?204, 1990","journal-title":"J Neuro-Oncol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ana.410180603","volume":"18","author":"JO Jarden","year":"1985","unstructured":"Jarden JO, Dhawan V, Poltorak A, Posner JB, Rottenberg DA: Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of82Rb: the effect of dexamethasone and whole-brain radiation therapy. Ann Neurol 18: 636?646, 1985","journal-title":"Ann Neurol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3171\/jns.1987.67.6.0880","volume":"67","author":"JN Bruce","year":"1987","unstructured":"Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock B, Oldfield EH: Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamthasone. J Neurosurg 67: 880?884, 1987","journal-title":"J Neurosurg"},{"key":"CR36","first-page":"2827","volume":"45","author":"EA Neuwelt","year":"1985","unstructured":"Neuwelt EA, Frenkel EP, D'Agostino AN, Carney DN, Minna JD, Barnett PA, McCormick CI: Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier. Cancer Res 45: 2827?2833 (1985)","journal-title":"Cancer Res"},{"key":"CR37","first-page":"694","volume":"48","author":"WR Shapiro","year":"1988","unstructured":"Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE: Pharmacokinetics of tumor ceil exposure to [14C]methotrexate after intracarotid administration without and with hyperosmolotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study. Cancer Res 48: 694?701, 1988","journal-title":"Cancer Res"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3171\/jns.1987.66.2.0256","volume":"66","author":"T Inoue","year":"1987","unstructured":"Inoue T, Fukui M, Nishio S, Kitamura K, Nagara H: Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor. J Neurosurg 66: 256?263, 1987","journal-title":"J Neurosurg"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1227\/00006123-198007000-00006","volume":"7","author":"EA Neuwelt","year":"1980","unstructured":"Neuwelt EA, Frenkel EP, Rapoport S, Barnett P: Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in dogs. Neurosurg 7: 36?13, 1980","journal-title":"Neurosurg"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1227\/00006123-198108000-00002","volume":"9","author":"NF Kassell","year":"1981","unstructured":"Kassell NF, Baumann KW, Hitchon PW, Gerk MK, Hill TR, Sokoll MD: Neurosurg 9: 283?286, 1981","journal-title":"Neurosurg"},{"key":"CR41","unstructured":"Villemure JG: personal communication"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/WNL.29.9_Part_1.1280","volume":"29","author":"H Hasegawa","year":"1979","unstructured":"Hasegawa H, Allen JC, Mehta BM, Shapiro WR, Posner JB: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis. Neurology 29: 1280?1286, 1979","journal-title":"Neurology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3171\/jns.1981.55.4.0550","volume":"55","author":"AM Burke","year":"1981","unstructured":"Burke AM, Quest DO, Chien S, Cerri C: The effects of mannitol on blood viscosity. J Neurosurg 55: 550?553, 1981","journal-title":"J Neurosurg"},{"key":"CR44","first-page":"315","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Richard MT, Hugenholtz H, Dennery J, Nundy D, Prior J, Montpetit V, Hopkins HS: Penetration of teniposide (VM-26) into human intracerebral tumors: preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin-B or oral glycerol. J Neuro-Oncol 2: 315?324, 1984","journal-title":"J Neuro-Oncol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1227\/00006123-198708000-00013","volume":"21","author":"DJ Stewart","year":"1987","unstructured":"Stewart DJ, Grahovac Z, Hugenholtz H, Russell N, Richard M, Benoit B: Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurg 21: 207?214, 1987","journal-title":"Neurosurg"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01054276","volume":"17","author":"DJ Stewart","year":"1993","unstructured":"Stewart DJ, Grahovac Z, Hugenholtz H, DaSilva V, Richard M, Benoit B, Belanger G, Russell N: Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. J Neuro Oncol 17: 71?79, 1993","journal-title":"J Neuro Oncol"},{"key":"CR47","first-page":"875","volume":"48","author":"VA Levin","year":"1972","unstructured":"Levin VA, Clancy TP, Ausman JI, Rall DP: Uptake and distribution of3H-methotroxate by the murine ependymoblastoma. J Natl Cancer Inst 48: 875?883, 1972","journal-title":"J Natl Cancer Inst"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3171\/jns.1974.40.6.0706","volume":"40","author":"Y Ushio","year":"1974","unstructured":"Ushio Y, Hayakawa T, Mogami H: Uptake of tritiated methotrexate by mouse brain tumors after intravenous or intrathecal administration. J Neurosurg 40: 706?716, 1974","journal-title":"J Neurosurg"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnci\/59.2.405","volume":"59","author":"I Wodinsky","year":"1977","unstructured":"Wodinsky I, Merker PC, Venditti JM: Responsiveness to chemotherapy of mice with L1210 lymphoid leukemia implanted in various anatomic sites. J Natl Cancer Inst 59: 405?408, 1977","journal-title":"J Natl Cancer Inst"},{"key":"CR50","first-page":"265","volume":"24","author":"FM Schabel Jr","year":"1983","unstructured":"Schabel FM Jr, Griswold DP Jr, Corbett TH, Laster WR Jr, Trader MW: Curative chemotherapy of advanced239Pu-induced osteosarcoma (239PU OS) in mice with 2-?-D-ribofuranosylthiazole-4-carboxamide (T-CAR) and of advanced L1210 with T-CAR plus BCNU. Proc Am Assoc Cancer Res 24: 265, 1983","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR51","first-page":"15","volume":"49","author":"MA Chirigos","year":"1965","unstructured":"Chirigos MA, Humphreys SR, Goldin A: Duration of effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. Cancer Chemother Rep 49: 15?19, 1965","journal-title":"Cancer Chemother Rep"},{"key":"CR52","first-page":"224","volume":"46","author":"HS Freidman","year":"1986","unstructured":"Freidman HS, Schold SC Jr, Bigner DD: Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice. Cancer Res 46: 224?228, 1986","journal-title":"Cancer Res"},{"key":"CR53","first-page":"729","volume":"59","author":"PC Merker","year":"1975","unstructured":"Merker PC, Wodinsky I, Geran RI: Review of selected experimental brain tumor models used in chemotherapy experiments. Cancer Chemother Rep 59: 729?736, 1975","journal-title":"Cancer Chemother Rep"},{"key":"CR54","first-page":"1325","volume":"60","author":"FM Schabel Jr","year":"1976","unstructured":"Schabel FM Jr, Trader MW, Laster WR Jr, Shaddix SC, Brockman RW: Studies with 2,5-piperazinedione,3,6-bis-(5-chloro-2-piperidyl)-dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. Cancer Treat Rep 60: 1325?1333, 1976","journal-title":"Cancer Treat Rep"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/archneur.1974.00490330030005","volume":"30","author":"WR Shapiro","year":"1974","unstructured":"Shapiro WR: The chemotherapy of intracerebral vs subcutaneous murine gliomas. A comparative study of the effect of VM-26. Arch Neurol 30: 222?226, 1974","journal-title":"Arch Neurol"},{"key":"CR56","first-page":"787","volume":"58","author":"VA Levin","year":"1974","unstructured":"Levin VA, Kabra P: Effectiveness of the nitrosoureas as a function of their lipid solubility in the chemotherapy of experimental rat brain tumors. Cancer Chemother Rep 58: 787?792, 1974","journal-title":"Cancer Chemother Rep"},{"key":"CR57","first-page":"327","volume":"59","author":"VA Levin","year":"1975","unstructured":"Levin VA, Crafts D, Wilson CB, Kabra P, Hansch C, Boldrey E, Enot J, Neely M: Imidazole Carboxamides: relationship of lipophilicity to activity against intracerebral murine glioma 26 and preliminary phase II trial of 5-[3,3-bis(2-chloroethy])-1-triazeno]imidazole-4-carboxamide (NSC-82196) in primary and secondary brain tumors. Cancer Chemoth Rep 59: 327?331, 1975","journal-title":"Cancer Chemoth Rep"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.1988.6.4.679","volume":"6","author":"The French Epirubicin Study Group","year":"1988","unstructured":"The French Epirubicin Study Group. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. J Clin Oncol 6: 679?688, 1988","journal-title":"J Clin Oncol"},{"key":"CR59","volume-title":"Cancer: Principles and Practice of Oncology","author":"IC Henderson","year":"1989","unstructured":"Henderson IC, Harris JR, Kinne DW, Hellman S: Cancer of the breast. Identifying chemotherapy-responsive patients. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds)Cancer: Principles and Practice of Oncology (3rd edition), JB Lippincott Co., Philadelphia, 1989","edition":"3rd edition"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/bjc.1989.291","volume":"60","author":"JB Sorensen","year":"1989","unstructured":"Sorensen JB, Badsberg JH, Hansen HH: Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications. Br J Cancer 60: 389?393, 1989","journal-title":"Br J Cancer"},{"key":"CR61","first-page":"1319","volume":"61","author":"MG Donelli","year":"1977","unstructured":"Donelli MG, Colombo T, Broggini M, Garattini S: Differential distribution of antitumor agents in primary and secondary tumors. Cancer Treat Rep 61: 1319?1324, 1977","journal-title":"Cancer Treat Rep"},{"key":"CR62","first-page":"555","volume":"67","author":"M Broggini","year":"1983","unstructured":"Broggini M, Colombo T, D'Incalci M: Activity and pharmacokinetics of teniposide in Lewis Lung Carcinomabearing mice. Cancer Treat Rep 67: 555?559, 1983","journal-title":"Cancer Treat Rep"},{"key":"CR63","first-page":"21","volume":"11","author":"J Talmadge","year":"1982","unstructured":"Talmadge J, Fidller I: Metastatic cancer and its biological heterogeneity. Rev Endocrine-Related Cancer 11: 21?27, 1982","journal-title":"Rev Endocrine-Related Cancer"},{"key":"CR64","first-page":"35","volume":"3","author":"J Ro","year":"1990","unstructured":"Ro J, Ro JY, El-Nagger A, Holmes FA, Close D, Hortobagyi GN: Brain metastasis initial presentation of breast cancer: DNA flow cytometric comparison of two sites. Breast Dis 3: 35?38, 1990","journal-title":"Breast Dis"},{"key":"CR65","first-page":"32","volume":"38","author":"G Nicolson","year":"1986","unstructured":"Nicolson G: Metastatic phenotypic diversity and brain metastasis. The Cancer Bulletin 38: 32?38, 1986","journal-title":"The Cancer Bulletin"},{"key":"CR66","first-page":"143","volume":"224","author":"N Zaffaroni","year":"1983","unstructured":"Zaffaroni N, Silvestrini R, Sanfilippo O, Daidone MG, De Marco C: Tumor heterogeneity: analysis of the chemosensitivity of different tumor sites of the same patient. Proc 13th Internat Congr Chemother 224: 143?146, 1983","journal-title":"Proc 13th Internat Congr Chemother"},{"key":"CR67","first-page":"2309","volume":"44","author":"N Tanigawa","year":"1984","unstructured":"Tanigawa N, Mizuno Y, Hashimura T, Honda K, Satomura K, Hikasa Y, Niwa O, Sugahara T, Yoshida O, Kern DH, Morton DL: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay. Cancer Res 44: 2309?2312, 1984","journal-title":"Cancer Res"},{"key":"CR68","first-page":"4086","volume":"42","author":"P Schlag","year":"1982","unstructured":"Schlag P, Schreml W: Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay. Cancer Res 42: 4086?4089, 1982","journal-title":"Cancer Res"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj1520701","volume":"152","author":"JJ Volpe","year":"1975","unstructured":"Volpe JJ, Fujimota K, Marasa JCet al.: Relation of C-6 ghal cells in culture to myelin. Biochem J 152: 701?703, 1975","journal-title":"Biochem J"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1073\/pnas.69.10.2885","volume":"69","author":"SE Pfeiffer","year":"1972","unstructured":"Pfeiffer SE, Wechsler W: Biochemically differentiated neoplastic clone of Schwann cells. Proc Natl Acad Sci USA 69: 2885?2889, 1972","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR71","first-page":"913","volume":"76","author":"E Horak","year":"1986","unstructured":"Horak E, Darling DL, Tarin D: Analysis of organ-specific effects on metastatic tumor formation by studiesin vitro. JNCI 76: 913?922, 1986","journal-title":"JNCI"},{"key":"CR72","first-page":"527","volume":"61","author":"LB Mellet","year":"1977","unstructured":"Mellet LB: Physicochemical considerations and pharmacokinetic behaviour in delivery of drugs to the central nervous system. Cancer Treat Rep 61: 527?531, 1977","journal-title":"Cancer Treat Rep"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3171\/jns.1981.55.6.0922","volume":"55","author":"K Yamada","year":"1981","unstructured":"Yamada K, Hayakawa T, Ushio Y, Arita N, Kato A, Magami H: Regional blood flow and capillary permeability in the ethylnitrosourea-induced rat glioma. J Neurosurg 55: 922?928, 1981","journal-title":"J Neurosurg"},{"key":"CR74","first-page":"571","volume":"34","author":"AW Vogel","year":"1965","unstructured":"Vogel AW: Intratumoral vascular changes with increased size of mammary adenocarcinomas: new method and results. J Nat Cancer Inst 34: 571?578, 1965","journal-title":"J Nat Cancer Inst"},{"issue":"Suppl 2","key":"CR75","first-page":"3","volume":"65","author":"R Blasberg","year":"1981","unstructured":"Blasberg R, Kobayashi T, Patlak C, Shinohara M, Mizoaka M, Rice J, Shapiro W: Regional blood flow, capillary permeability and glucose utilization in two brain tumor models: preliminary observations and pharmacokinetic implications. Cancer Treat Rep 65 (Suppl 2): 3?12, 1981","journal-title":"Cancer Treat Rep"},{"key":"CR76","first-page":"3643","volume":"44","author":"JH Goldie","year":"1984","unstructured":"Goldie JH, Coldman AJ: The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 44: 3643?3653, 1984","journal-title":"Cancer Res"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V37.3.272.272","volume":"37","author":"RJA Aur","year":"1971","unstructured":"Aur RJA, Simone J, Hustu HOet al.: Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood 37: 272?281, 1971","journal-title":"Blood"},{"key":"CR78","first-page":"675","volume":"67","author":"RS Aroney","year":"1983","unstructured":"Aroney RS, Aisner J, Wesley MN, Whitacre MY, Van Echo DA, Slawson RG, Wiernik PH: Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat Rep 67: 675?682, 1983","journal-title":"Cancer Treat Rep"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F","volume":"44","author":"JL Nugent","year":"1979","unstructured":"Nugent JL, Bunn PA Jr, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD: CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885?1893, 1979","journal-title":"Cancer"},{"key":"CR80","first-page":"1","volume":"61","author":"M Alexander","year":"1977","unstructured":"Alexander M, Glatstein EJ, Gordon DJ, Daniels JR: Combined modality treatment for oat cell carcinoma of the lung: a randomized trial. Cancer Treat Rep 61: 1?6, 1977","journal-title":"Cancer Treat Rep"},{"key":"CR81","first-page":"505","volume":"22","author":"KR Hande","year":"1981","unstructured":"Hande KR, Oldham RK, Fer MF, Richardson RL, Greco FA: A randomized trial of high-dose (HD) vs low dose (LD) methotrexate (MTX) in the treatment of extensive stage small cell lung cancer. Proc Am Assoc Cancer Res & Am Soc Clin Oncol 22: 505, 1981","journal-title":"Proc Am Assoc Cancer Res & Am Soc Clin Oncol"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00000421-198506000-00005","volume":"8","author":"HG Seydel","year":"1985","unstructured":"Seydel HG, Creech R, Pagano M, Salazar O, Rubin P, Concannon J, Carbone P, Mohuiddin M, Perez C, Matthews M: Prophylactic versus no brain irradiation in regional small cell lung carcinoma. Am J Clin Oncol (CCT) 8: 218?223, 1985","journal-title":"Am J Clin Oncol (CCT)"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1097-0142(19810101)47:1<41::AID-CNCR2820470109>3.0.CO;2-M","volume":"47","author":"RJ Baglan","year":"1981","unstructured":"Baglan RJ, Marks JE: Comparison of symptomatic and prophylactic irradiation of brain metastases from oat cell carcinoma of the lung. Cancer 47: 41?45, 1981","journal-title":"Cancer"},{"key":"CR84","first-page":"35","volume":"2","author":"R Komaki","year":"1985","unstructured":"Komaki R: Prophylactic cranial irradiation for small cell carcinoma of the lung. Cancer Treat Symp 2: 35?39, 1985","journal-title":"Cancer Treat Symp"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19800101)45:1<30::AID-CNCR2820450107>3.0.CO;2-6","volume":"45","author":"LH Maurer","year":"1980","unstructured":"Maurer LH, Tulloh M, Weiss RBet al.: A randomized combined modality trial in small cell carcinoma of the lung. Cancer 45: 30?39, 1980","journal-title":"Cancer"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1985.3.6.776","volume":"3","author":"SL George","year":"1985","unstructured":"George SL, Ochs JJ, Mauer AM, Simone JV: The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia. J Clin Oncol 3: 776?781, 1985","journal-title":"J Clin Oncol"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/1097-0142(197408)34:2<418::AID-CNCR2820340227>3.0.CO;2-X","volume":"34","author":"FS Muriel","year":"1974","unstructured":"Muriel FS, Pavlovsky S, Penalver JA, Hidalgo G, Bonesana AC, Eppinger-Helft M, De Macchi GH, Pavlovsky A: Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia. Cancer 34: 418?426, 1974","journal-title":"Cancer"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.2.5863.381","volume":"2","author":"Working Party on Leukemia in Childhood","year":"1973","unstructured":"Working Party on Leukemia in Childhood. Treatment of acute lymphoblastic leukemia: effect of ?prophylactic? therapy against central nervous system leukemia. Br Med J 2: 381?384, 1973","journal-title":"Br Med J"},{"key":"CR89","first-page":"674","volume":"42","author":"ME Nesbit","year":"1982","unstructured":"Nesbit ME, Sather H, Robison LL, Donaldson M, Littman P, Ortega JA, Hammond GD: Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia. A report from Childrens Cancer Study Group. Cancer Res 42: 674?680, 1982","journal-title":"Cancer Res"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/1097-0142(19811115)48:10<2147::AID-CNCR2820481005>3.0.CO;2-S","volume":"48","author":"TR Lininger","year":"1981","unstructured":"Lininger TR, Fleming TR, Eagen RT: Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancer. Cancer 48: 2147?2153, 1981","journal-title":"Cancer"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood.V26.2.133.133","volume":"26","author":"BA Nies","year":"1965","unstructured":"Nies BA, Bodey GP, Thomas LB, Brecher G, Freireich EJ: The persistence of extramedullary leukemic infiltrates during bone marrow remission of acute leukemia. Blood 26: 133?141, 1965","journal-title":"Blood"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.V39.6.759.759","volume":"39","author":"JV Simone","year":"1972","unstructured":"Simone JV, Holland E, Johnson W: Fatalities during remission of childhood leukemia. Blood 39: 759?770, 1972","journal-title":"Blood"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.1.5488.640","volume":"1","author":"G Mathe","year":"1966","unstructured":"Mathe G, Schwarzenberg L, Mery AM, Cattan A, Schneider M, Amiel JL, Schlumberger JR, Poisson J, Wajcner G: Extensive histological and cytological survey of patients with acute leukemia in ?complete remission?. Br Med J 1: 640?642, 1966","journal-title":"Br Med J"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0142(19810101)47:1<184::AID-CNCR2820470130>3.0.CO;2-M","volume":"47","author":"DJ Stewart","year":"1981","unstructured":"Stewart DJ, Keating MJ, McCredie KB, Smith TL, Murphy SG, Bodey GP, Freireich EJ: Natural history of central nervous system acute leukemia in adults. Cancer 47: 184?196, 1981","journal-title":"Cancer"},{"key":"CR95","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/1097-0142(19800415)45:8<2017::AID-CNCR2820450806>3.0.CO;2-C","volume":"42","author":"MJ Keating","year":"1980","unstructured":"Keating MJ, Smith BS, Gehan EA, McCredie KB, Bodey GP, Spitzer G, Hersh E, Gutterman J, Freireich EJ: Factors related to length of complete remission in adult acute leukemia. Cancer 42: 2017?2029, 1980","journal-title":"Cancer"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/bmj.3.5822.311","volume":"3","author":"RJ West","year":"1972","unstructured":"West RJ, Graham-Pole J, Hardisty RM, Pike MD: Factors in pathogenesis of central nervous system leukemia. Br Med J 3: 311?314, 1972","journal-title":"Br Med J"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(78)91509-X","volume":"ii","author":"JH Baumer","year":"1978","unstructured":"Baumer JH, Mott MG: Sex and prognosis in childhood acute lymphoblastic leukemia. Lancet ii: 128?129, 1978","journal-title":"Lancet"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1097-0142(197808)42:2<781::AID-CNCR2820420250>3.0.CO;2-P","volume":"42","author":"SL George","year":"1978","unstructured":"George SL, Fernbach DJ, Lu ET: Early deaths in newly diagnosed cases of pediatric acute leukemia. A Southwest Oncology Group Study. Cancer 42: 781?786, 1978","journal-title":"Cancer"},{"key":"CR99","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(197309)32:3<585::AID-CNCR2820320311>3.0.CO;2-K","volume":"32","author":"H Hustu","year":"1973","unstructured":"Hustu H, Aur RJA, Verzosa MS, Simone JV, Pinkel D: Prevention of central nervous system leukemia by irradiation. Cancer 32: 585?597, 1973","journal-title":"Cancer"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0360-3016(88)90351-3","volume":"15","author":"A Sadeghi","year":"1988","unstructured":"Sadeghi A, Payne D, Rubinstein L, Lad T, the Lung Cancer Study Group: Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence. Int J Radiation Oncology Biol Phys 15: 89?97, 1988","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"CR101","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/1097-0142(19820215)49:4<651::AID-CNCR2820490408>3.0.CO;2-X","volume":"49","author":"AHG Paterson","year":"1982","unstructured":"Paterson AHG, Agarwal M, Lees A, Hanson J, Szafran O: Brain metastases in breast cancer patients receiving adjuvant chemotherapy. Cancer 49: 651?654, 1982","journal-title":"Cancer"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM197602192940801","volume":"294","author":"G Bonadonna","year":"1976","unstructured":"Bonadonna G, Brussamelino E, Valagussa Pet al.: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 405?410, 1976","journal-title":"N Engl J Med"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/030089168106700515","volume":"67","author":"K Kolaric","year":"1981","unstructured":"Kolaric K, Roth A, Jelicic I, Matkovic A: A preliminary report on antitumorigenic activity of cisdichlorodiammineplatinum in metastatic brain tumors. Tumori 67: 483?486, 1981","journal-title":"Tumori"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00182958","volume":"1","author":"D Rosner","year":"1983","unstructured":"Rosner D, Nemoto T, Pickren J, Lane W: Management of brain metastases from breast cancer by combination chemotherapy. J Neuro-Oncol 1: 131?137, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00007611-198404000-00005","volume":"77","author":"H Kantarajian","year":"1984","unstructured":"Kantarajian H, Farha PAM, Spitzer G, Murphy WK, Valdivieso M: Systemic combination chemotherapy as primary treatment of brain metastases from lung cancer. Southern Med J 77: 426?430, 1984","journal-title":"Southern Med J"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1200\/JCO.1989.7.7.916","volume":"7","author":"JS Lee","year":"1989","unstructured":"Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK: Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 7: 916?922, 1989","journal-title":"J Clin Oncol"},{"key":"CR107","first-page":"140","volume":"1","author":"JA Maroun","year":"1982","unstructured":"Maroun JA, Stewart DJ, Young V, Belanger R, Crook AF: Effectiveness of VM-26 in non-small cell carcinoma of the lung (NSCCL) with central nervous system (CNS) metastases. Preliminary Results. Proc Am Soc Clin Oncol 1: 140, 1982","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR108","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/1097-0142(19820501)49:9<1916::AID-CNCR2820490926>3.0.CO;2-8","volume":"49","author":"E Robin","year":"1982","unstructured":"Robin E, Bitran JD, Golomb HM, Newman S, Hoffman PC, Desser RK, DeMeester TR: Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer 49: 1916?1919, 1982","journal-title":"Cancer"},{"key":"CR109","first-page":"105","volume":"2","author":"M Casimir","year":"1983","unstructured":"Casimir M, Yap H, Atkinson N, Hortobagyi G, Buzdar A, Fleishman G, Blumenschein G: Prognostic factors for survival of breast cancer (BC) patients (PTS) with central nervous system (CNS) metastases. Proc Am Soc Clin Oncol 2: 105, 1983","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/1097-0142(19830301)51:5<933::AID-CNCR2820510528>3.0.CO;2-Q","volume":"51","author":"GA Hazel Van","year":"1983","unstructured":"Van Hazel GA, Scott M, Eagen RT: The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer 51: 933?937, 1983","journal-title":"Cancer"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/1097-0142(197701)39:1<303::AID-CNCR2820390147>3.0.CO;2-U","volume":"39","author":"VJ Lanzotti","year":"1977","unstructured":"Lanzotti VJ, Thomas DR, Boyle LE, Smith TL, Gehan EA, Samuels ML: Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria. Cancer 39: 303?313, 1977","journal-title":"Cancer"},{"key":"CR112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.1988.6.1.89","volume":"6","author":"A Goldhirsch","year":"1988","unstructured":"Goldhirsch A, Gelber RD, Castiglione M for the Ludwig Breast Cancer Study Group: Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol 6: 89?97, 1988","journal-title":"J Clin Oncol"},{"key":"CR113","first-page":"632","volume-title":"Cancer;Principles and Practice of Oncology","author":"JD Minna","year":"1989","unstructured":"Minna JD, Pass H, Glatstein E, Ihde DC: Cancer of the Lung. Prognostic factors. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds)Cancer;Principles and Practice of Oncology (3rd edition) JB Lippincott Co., Philadelphia, 1989, p 632","edition":"3rd edition"},{"key":"CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00686477","volume":"30","author":"T Shinaki","year":"1992","unstructured":"Shinaki T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Miya T, Okamoto H, Iemura K, Saijo N: A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy. Cancer Chemother Pharmacol 30: 1?6, 1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1200\/JCO.1986.4.11.1604","volume":"4","author":"JP O'Connell","year":"1986","unstructured":"O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, Kelsen DP, Heelan RT, Golbey RB: Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol 4: 1604?1614, 1986","journal-title":"J Clin Oncol"},{"key":"CR116","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1097-0142(197807)42:1<27::AID-CNCR2820420105>3.0.CO;2-3","volume":"42","author":"GT Kennealey","year":"1978","unstructured":"Kennealey GT, Boston B, Mitchell MS, Knobf MK, Bobrow SN, Pezzimenti JF, Lawrence R, Bertino JR: Combination chemotherapy for advanced breast cancer. Two regimens containing Adriamycin. Cancer 42: 27?33, 1978","journal-title":"Cancer"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00182958","volume":"1","author":"D Rosner","year":"1983","unstructured":"Rosner D, Nemoto T, Pickren J, Lane W: Management of brain metastases from breast cancer by combination chemotherapy. J Neuro-Oncol 1: 131?137, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR118","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0305-7372(84)90006-9","volume":"11","author":"NH Greig","year":"1984","unstructured":"Greig NH: Chemotherapy of brain metastases: current status. Cancer Treat Rev 11: 157?186, 1984","journal-title":"Cancer Treat Rev"},{"key":"CR119","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1227\/00006123-198306000-00013","volume":"12","author":"EA Neuwelt","year":"1983","unstructured":"Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E: Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurg 12: 662?671, 1983","journal-title":"Neurosurg"},{"key":"CR120","first-page":"287","volume":"67","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, Russell N, Quarrington A, Atack E, Stolbach L: Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of brain. Cancer Treat Rep 67: 287?291, 1983","journal-title":"Cancer Treat Rep"},{"key":"CR121","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-1-4613-2297-9_59","volume-title":"Biology of Brain Tumor","author":"DJ Stewart","year":"1986","unstructured":"Stewart DJ, Russell N, Dennery J, Richard MT, Atack E, Eapen L, Girard A, Maroun JA, Grahovac Z, Belanger G: Cyclophosphamide, Adriamycin, vincristine, and dexamethasone in the treatment of bulky central nervous system lymphoma. In: Walker MD, Thomas DGT (eds)Biology of Brain Tumor, Martinus Nijhoff Publishers, Boston, 1986, pp 433?436"},{"key":"CR122","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3171\/jns.1985.62.4.0522","volume":"62","author":"Y Kawakami","year":"1985","unstructured":"Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A: Primary central nervous system lymphoma. J Neurosurg 62: 522?527, 1985","journal-title":"J Neurosurg"},{"key":"CR123","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/1097-0142(19900115)65:2<322::AID-CNCR2820650223>3.0.CO;2-D","volume":"65","author":"G Socie","year":"1990","unstructured":"Socie G, Pipot-Chauffat C, Schlienger M, Legars D, Thurel C, Mikol J, Ifran N, Briere J, Pene F, Gindrey-Vie B, Marin JL, Desablens B, Laugier A: Primary lymphoma of the central nervous system. An unresolved therapeutic problem. Cancer 65: 322?326, 1990","journal-title":"Cancer"},{"key":"CR124","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/1097-0142(19900501)65:9<1907::AID-CNCR2820650906>3.0.CO;2-L","volume":"65","author":"Y Shibamoto","year":"1990","unstructured":"Shibamoto Y, Tsutsui K, Dodo Y, Yamabe H, Shima N, Abe M: Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65: 1907?1912, 1990","journal-title":"Cancer"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3171\/jns.1988.68.6.0835","volume":"68","author":"FH Hochberg","year":"1988","unstructured":"Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68: 835?853, 1988","journal-title":"J Neurosurg"},{"key":"CR126","first-page":"1776","volume-title":"Cancer: principles and Practice of Oncology","author":"VT Vita De Jr","year":"1989","unstructured":"De Vita VT Jr, Jaffe ES, Mauch P, Longo DL: Lymphocytic lymphomas. Treatment of localized aggressive lymphomas. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds)Cancer: principles and Practice of Oncology (3rd edition), JB Lippincott Co., Philadelphia, 1989, pp 1776?1777","edition":"3rd edition"},{"key":"CR127","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3171\/jns.1986.65.5.0600","volume":"65","author":"K Murray","year":"1986","unstructured":"Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 65: 600?607, 1986","journal-title":"J Neurosurg"},{"key":"CR128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0305-7372(89)90007-8","volume":"16","author":"DJ Stewart","year":"1989","unstructured":"Stewart DJ: The role of chemotherapy in the treatment of gliomas in adults. Cancer Treatment Reviews 16: 129?160, 1989","journal-title":"Cancer Treatment Reviews"},{"key":"CR129","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0046-8177(75)80045-1","volume":"6","author":"A Hirano","year":"1975","unstructured":"Hirano A, Matsui T: Vascular structures in brain tumors. Hum Pathol 6: 611?621, 1975","journal-title":"Hum Pathol"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3171\/jns.1970.32.2.0127","volume":"32","author":"DM Long","year":"1970","unstructured":"Long DM: Capillary ultrastructure and the blood brainbarrier in human malignant brain tumors. J Neurosurg 32: 127?144, 1970","journal-title":"J Neurosurg"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00148386","volume":"5","author":"BL Coomber","year":"1987","unstructured":"Coomber BL, Stewart PA, Hayakawa K, Farrell CL, Del Maestro RF: Quantitative morphology of human glioblastoma multiforme microvessels: structural basis of bloodbrain barrier defect. J Neuro-Oncol 5: 299?307, 1987","journal-title":"J Neuro-Oncol"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S","volume":"71","author":"HA Fine","year":"1992","unstructured":"Fine HA, Dear KBG, Loeffler JS, Black PMcL, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585?2597, 1992","journal-title":"Cancer"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/1097-0142(197505)35:5<1398::AID-CNCR2820350524>3.0.CO;2-C","volume":"35","author":"PH Gutin","year":"1975","unstructured":"Gutin PH, Wilson CB, Kumar ARV, Boldrey EB, Levin V, Powell M, Enot KJ: Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors. Cancer 35: 1398?1404, 1975","journal-title":"Cancer"},{"key":"CR134","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.1983.1.1.38","volume":"1","author":"RT Eagan","year":"1983","unstructured":"Eagan RT, Scott M: Evaluation of prognostic factors in chemotherapy of recurrent brain tumors. J Clin Oncol 1: 38?44, 1983","journal-title":"J Clin Oncol"},{"key":"CR135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/07357908609039831","volume":"4","author":"I Nir","year":"1986","unstructured":"Nir I, Kohn S, Doron Y, Israel O, Front D: Quantitative analysis of tight junctions and the uptake of99mTc in human gliomas. Cancer Investig 4: 519?524, 1986","journal-title":"Cancer Investig"},{"key":"CR136","unstructured":"Long D: Capillary ultrastructure and the blood brain barrier. Human brain tumors. 6th Int Congr Neuropath, Paris 1970, pp 994?996"},{"key":"CR137","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00149372","volume":"7","author":"SJ Bertolone","year":"1989","unstructured":"Bertolone SJ, Baum ES, Krivit W, Hammond GD: A phase II study of cisplatin therapy in recurrent childhood brain tumors. J Neuro-Oncol 7: 5?11, 1989","journal-title":"J Neuro-Oncol"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3171\/jns.1985.63.6.0862","volume":"63","author":"JG Rosenstock","year":"1985","unstructured":"Rosenstock JG, Packer RJ, Bilaniuk L, Bruce DA, Radcliffe J-L, Savino P: Chiasmatic optic glioma treated with chemotherapy. J Neurosurg 63: 862?866, 1985","journal-title":"J Neurosurg"},{"key":"CR139","first-page":"65","volume":"3","author":"M Mahaley","year":"1984","unstructured":"Mahaley M, Urso M, Whaley R, Silker R, Williams T, Guaspari A: Malignant glioma treatment with interferon. Proc Am Soc Clin Oncol 3: 65, 1984","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/1097-0142(197402)33:2<460::AID-CNCR2820330222>3.0.CO;2-5","volume":"33","author":"BD Sklansky","year":"1974","unstructured":"Sklansky BD, Mann-Kaplan RS, Reynolds AF, Rosenblum ML, Walker MD: 4?-Demethyl-epipodophyllotoxin-?-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms. Cancer 33: 460?467, 1974","journal-title":"Cancer"},{"key":"CR141","first-page":"419","volume":"12","author":"K Takeuchi","year":"1975","unstructured":"Takeuchi K: A clinical trial of intravenous bleomycin in the treatment of brain tumors. Int J Clin Pharmacol 12: 419?426, 1975","journal-title":"Int J Clin Pharmacol"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3171\/jns.1976.45.2.0135","volume":"45","author":"JG Rosenstock","year":"1976","unstructured":"Rosenstock JG, Evans AE, Schut L: Response to vincristine of recurrent brain tumors in children. J Neurosurg 45: 135?140, 1976","journal-title":"J Neurosurg"},{"issue":"Suppl 2","key":"CR143","first-page":"37","volume":"12","author":"ES Newlands","year":"1985","unstructured":"Newlands ES: VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma. Sem Oncol 12 (Suppl 2): 37?41, 1985","journal-title":"Sem Oncol"},{"key":"CR144","first-page":"793","volume":"65","author":"RW Carey","year":"1981","unstructured":"Carey RW, Davis JM, Zervas NT: Tamoxifen-induced regression of cerebral metastases in breast carcinoma. Cancer Treat Rep 65: 793?795, 1981","journal-title":"Cancer Treat Rep"},{"key":"CR145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02228891","volume":"3","author":"JC Allen","year":"1985","unstructured":"Allen JC, Bosl G, Walker R: Chemotherapy trials in recurrent primary intracranial germ cell tumors. J Neuro-Oncol 3: 147?152, 1985","journal-title":"J Neuro-Oncol"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/1097-0142(197510)36:4<1269::AID-CNCR2820360412>3.0.CO;2-#","volume":"36","author":"SG Taylor IV","year":"1975","unstructured":"Taylor SG IV, Nelson L, Baxter D, Rosenbaum C, Spongo RW, Cunningham TG, Olson KB, Horton J: Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441). Cancer 36: 1269?1276, 1975","journal-title":"Cancer"},{"key":"CR147","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3171\/jns.1986.65.4.0470","volume":"65","author":"Y Kida","year":"1986","unstructured":"Kida Y, Kobayashi T, Yoshida J, Kato K, Kageyama N: Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous system. J Neurosurg 65: 470?475, 1986","journal-title":"J Neurosurg"},{"key":"CR148","first-page":"145","volume":"1","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, O'Bryan M, Al-Sarraf M, Costanzi JJ, Oishi N: Phase II study of cisplatin in recurrent astrocytomas in adults. J Neuro-Oncol 1: 145?147, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR149","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00165155","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Richard M, Hugenholtz HN, Benoit B, Russell N, Dennery J, Peterson E, Maroun JA: Cisplatin plus cytosine arabinoside in adults with malignant gliomas. J Neuro-Oncol 2: 29?34, 1984","journal-title":"J Neuro-Oncol"},{"key":"CR150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3171\/jns.1981.55.5.0749","volume":"55","author":"JC Allen","year":"1981","unstructured":"Allen JC, Helson J: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55: 749?756, 1981","journal-title":"J Neurosurg"},{"key":"CR151","first-page":"725","volume":"60","author":"MD Walker","year":"1976","unstructured":"Walker MD, Hilton J: Nitrosourea pharmacodynamics in relation to the central nervous system. Cancer Treat Rep 60: 725?728, 1976","journal-title":"Cancer Treat Rep"},{"key":"CR152","first-page":"841","volume":"61","author":"S Eckhardt","year":"1977","unstructured":"Eckhardt S, Csetenyi J, Horvath IP, Kerpel-Fronius S, Szamel I, Institoris L, Szlovik F, Pasztor E, Afra D: Uptake of labelled dianhydrogalactitol into human gliomas and nervous tissue. Cancer Treat Rep 61: 841?847, 1977","journal-title":"Cancer Treat Rep"},{"key":"CR153","first-page":"1035","volume":"125","author":"Y Ojima","year":"1967","unstructured":"Ojima Y, Sullivan RD: Pharmacology of methotrexate in the human central nervous system. Surg Gyn Obs 125: 1035?1040, 1967","journal-title":"Surg Gyn Obs"},{"key":"CR154","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jnnp.39.4.341","volume":"39","author":"T Hayakawa","year":"1976","unstructured":"Hayakawa T, Ushio Y, Morimoto K, Hasegawa H, Mogami H, Horibata K: Uptake of bleomycin by human brain tumors. J Neurol Neurosurg Psych 39: 341?349, 1976","journal-title":"J Neurol Neurosurg Psych"},{"key":"CR155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02074426","volume":"13","author":"G Simon","year":"1965","unstructured":"Simon G, Graul EH, Hundeshagen H: Tracer-studien mit radioactiv markiertem cyclophosphamid bei hirntumoren. Acta Neurochir Wien 13: 441?156, 1965","journal-title":"Acta Neurochir Wien"},{"key":"CR156","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(1967)20:5<896::AID-CNCR2820200551>3.0.CO;2-D","volume":"20","author":"EH Graul","year":"1967","unstructured":"Graul EH, Schaumloffel E, Hundeshagen Het al.: Metabolism of radioactive cyclophosphamide: animal tests and clinical studies. Cancer 20: 896?899, 1967","journal-title":"Cancer"},{"key":"CR157","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0090-3019(81)80022-5","volume":"15","author":"K Haranda","year":"1980","unstructured":"Haranda K, Kiya K, Uozumi T: Pharmacokinetics of a new water-soluble nitrosourea derivative (ACNU) in human gliomas. Surg Neurol 15: 410?414, 1980","journal-title":"Surg Neurol"},{"key":"CR158","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0277-5379(90)90286-3","volume":"26","author":"I Sziklai","year":"1990","unstructured":"Sziklai I, Afra D, Ordogh M, Institoris L, Kerpel-Fronius S, Szabo E: The distribution of bromine content of dibromodulcitol in the central nervous system of patients with malignant gliomas. Eur J Cancer 26: 79?82, 1990","journal-title":"Eur J Cancer"},{"key":"CR159","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00162769","volume":"5","author":"N Savaraj","year":"1987","unstructured":"Savaraj N, Feun LG, Lu K, Leavens M, Moser R, Fields WS: Central nervous system (CNS) penetration of homoharringtonine (HHT). J Neuro-Oncol 5: 77?81, 1987","journal-title":"J Neuro-Oncol"},{"key":"CR160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/bjc.1991.147","volume":"63","author":"EA Lien","year":"1991","unstructured":"Lien EA, Wester K, Lonning PE, Solheim E, Ueland PM: Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. Br J Cancer 63: 641?645, 1991","journal-title":"Br J Cancer"},{"key":"CR161","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00257239","volume":"10","author":"DJ Stewart","year":"1982","unstructured":"Stewart DJ, Benjamin RS, Luna M, Scifert WE, Loo TL: Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemother & Pharm 10: 51?54, 1982","journal-title":"Cancer Chemother & Pharm"},{"key":"CR162","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.1992.10.5.795","volume":"10","author":"RW Gregg","year":"1992","unstructured":"Gregg RW, Stewart DJ, Molepo JM, Montpetit VJA, Mikhael NZ, Redmond D, Gadia M: Cisplatin neurotoxicity ? the relationship between dosage, time, platinum concentration in neurological tissues and morphological evidence of toxicity. J Clin Oncol 10: 795?803, 1992","journal-title":"J Clin Oncol"},{"key":"CR163","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00735922","volume":"32","author":"DJ Stewart","year":"1993","unstructured":"Stewart DJ, Grewaal D, Green R, Goel R, Mikhael N, Montpetit VAJ, Redmond D, Earhart R: Human autopsy tissue distribution of menogaril and its metabolites. Cancer Chemotherapy and Pharmacology 32: 373?378, 1993","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"CR164","first-page":"139","volume":"1","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, Lu K, Benjamin RS, Leavens M, Luna M, Yap HY, Loo TL: Concentrations of vinblastine in human intracerebral tumor and other tissues. J Neuro-Oncol 1: 139?144, 1983","journal-title":"J Neuro-Oncol"},{"key":"CR165","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00735921","volume":"32","author":"DJ Stewart","year":"1993","unstructured":"Stewart DJ, Grewaal D, Redmond D, Mikhael N, Montpetit V, Goel R, Green R: Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide. Cancer Chemotherapy and Pharmacology 32: 368?372, 1993","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"CR166","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF00254602","volume":"12","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Zhengang G, Lu K, Savaraj N, Feun LG, Benjamin RS, Keating MJ, Loo TL: Human tissue distribution of 4?-(9-Acridinylamino)-methanesulfon-m-aniside (NSC 14159, AMSA). Cancer Chemotherapy and Pharmacology 12: 116?119, 1984","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"CR167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00258210","volume":"7","author":"DJ Stewart","year":"1981","unstructured":"Stewart DJ, Rosenblum M, Luna M, Loo TL: Disposition of methylglyoxyl bis (Guanylhydrazone) (MGBG, NSC-32946) in man. Cancer Chemotherapy and Pharmacol 7: 31?35, 1981","journal-title":"Cancer Chemotherapy and Pharmacol"},{"key":"CR168","first-page":"349","volume":"39","author":"JA Benvenuto","year":"1979","unstructured":"Benvenuto JA, Hall SW, Farquhar D, Stewart DJ, Benjamin RS, Loo TL: Clinical pharmacology of 3-deazauridine. Cancer Research 39: 349?352, 1979","journal-title":"Cancer Research"},{"key":"CR169","first-page":"4119","volume":"39","author":"DJ Stewart","year":"1979","unstructured":"Stewart DJ, Benvenuto JA, Leavens M, Hall SW, Benjamin RS, Plunkett W, McCredie KD, Burgess MA, Loo TL: Penetration of 3-deazauridine into human brain, intracerebral tumor and cerebrospinal fluid. Cancer Research 39: 4119?1122, 1979","journal-title":"Cancer Research"},{"key":"CR170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00254260","volume":"11","author":"WE Seifert Jr","year":"1983","unstructured":"Seifert WE Jr, Stewart DJ, Dolupski JB, Benjamin RS, Caprioli RM: Energy dispersive x-ray fluorescence determination of platinum in plasma, urine, and CSF of patients administered cis-Dichlorodiammineplatinum (II). Cancer Chemotherapy and Pharmacology 11: 120?123, 1983","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"CR171","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/07357908309020272","volume":"1","author":"G Zhengang","year":"1983","unstructured":"Zhengang G, Savaraj N, Feun LG, Lu K, Stewart DJ, Luna M, Benjamin RS, Loo TL: Tumor penetration of AMSA in man. Cancer Investigation 1: 475?478, 1983","journal-title":"Cancer Investigation"},{"key":"CR172","first-page":"86","volume":"40","author":"TL Loo","year":"1980","unstructured":"Loo TL, Friedman E, Moore EC, Valdivieso M, Marti JR, Stewart DJ: The pharmacologic disposition of N-(phosphonacetyl)-L-aspartate in humans. Cancer Research 40: 86?90, 1980","journal-title":"Cancer Research"},{"key":"CR173","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cpt197925182","volume":"25","author":"SW Hall","year":"1979","unstructured":"Hall SW, Yeung K, Benjamin RS, Stewart DJ, Valdivieso M, Bedikian AY, Loo TL: Kinetics of gallium nitrate: a new anticancer agent. Clinical Pharmacology and Therapeutics 25: 82?87, 1979","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"Suppl","key":"CR174","first-page":"S27","volume":"7","author":"DJ Stewart","year":"1989","unstructured":"Stewart DJ, Grewaal D, Green RM, Mikhael N, Montpetit V, Redmond D; Adriamycin concentrations in human autopsy intracerebral and extracerebral tumors. J Neuro-Oncol 7 (Suppl): S27, 1989","journal-title":"J Neuro-Oncol"},{"key":"CR175","first-page":"180","volume":"31","author":"DJ Stewart","year":"1990","unstructured":"Stewart DJ, Molepo JM, Green R, Hugenholtz H, Lamothe A, Montpetit VJA, Redmond MD, Mikhael NZ: Factors affecting tumor cisplatin levels. Proc Am Assoc Cancer Res 31: 180, 1990","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR176","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0360-3016(94)90082-5","volume":"28","author":"DJ Stewart","year":"1994","unstructured":"Stewart DJ, Molepo M, Eapen L, Montpetit V, Goel R, Wong P, Popovic P, Taylor K, Raaphorst GP: Cisplatin and radiation in the treatment of tumors of the central nervous system: pharmacological considerations and results of early studies. Internat J Radiation Biol Phys. 28: 531?542, 1994","journal-title":"Internat J Radiation Biol Phys."},{"key":"CR177","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005072-198905000-00216","volume":"48","author":"VJA Montpetit","year":"1989","unstructured":"Montpetit VJA, Stewart D, Molepo JM, Mikhael N, Dancea S, Keaney MA: Cisplatinum neurotoxicity in ferrets: correlation of platinum concentration in neural tissues with sensory neuropathy. J Neuropathol Exp Neurol 48: 371, 1989","journal-title":"J Neuropathol Exp Neurol"},{"key":"CR178","first-page":"1437","volume":"70","author":"M DeGregorio","year":"1986","unstructured":"DeGregorio M, Wilbur B, King O, Wallenberg J, Prewitt S, Phillips J, Wilbur J: Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration. Cancer Treat Rep 70: 1437?1438, 1986","journal-title":"Cancer Treat Rep"},{"key":"CR179","first-page":"1441","volume":"69","author":"MW DeGregorio","year":"1985","unstructured":"DeGregorio MW, King OY, Holleran WM, Wilbur BJ, Cadman EC, Deisseroth AB, Wilbur JR: Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma. Cancer Treat Rep 69: 1441?1442, 1985","journal-title":"Cancer Treat Rep"},{"key":"CR180","first-page":"1661","volume":"66","author":"EM Bonnern","year":"1982","unstructured":"Bonnern EM, Litterst CL, Smith FP: Platinum concentrations in human glioblastoma multiforme following the use of cisplatin. Cancer Treat Rep 66: 1661?1663, 1982","journal-title":"Cancer Treat Rep"},{"key":"CR181","first-page":"464","volume":"33","author":"P Popovic","year":"1992","unstructured":"Popovic P, Wong PTT, Goel R, Evans WK, Howell SB, Auersperg N, Stewart DJ: Pressure-tuning infrared spectroscopy of cisplatin sensitive vs resistant ovarian cancer cells. Proc Amer Assoc Cancer Res 33: 464, 1992","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"CR182","first-page":"405","volume":"34","author":"P Popovic","year":"1993","unstructured":"Popovic P, Teicher B, Wong PTT, Goel R, Stewart DJ: Pressure tuning infrared spectroscopy of EMT-6 tumor and its cyclophosphamide- and cisplatin-resistant variants. Proc AACR 34: 405, 1993","journal-title":"Proc AACR"},{"key":"CR183","first-page":"3258","volume":"46","author":"P Vrignaud","year":"1986","unstructured":"Vrignaud P, Montaudon D, Londos-Gagliardi D, Robert J: Fatty acid composition transport and metabolism in doxorubicin-sensitive and -resistant rat glioblastoma cells. Cancer Res 46: 3258?3261, 1986","journal-title":"Cancer Res"},{"key":"CR184","first-page":"401","volume":"34","author":"KD Taylor","year":"1993","unstructured":"Taylor KD, Goel R, Stewart DJ, Wong PTT: Pressure tuning spectroscopic of cisplatin induced changes in a phosphatidylcholine model membrane. Proc AACR 34: 401, 1993","journal-title":"Proc AACR"},{"key":"CR185","first-page":"448","volume":"33","author":"KD Taylor","year":"1992","unstructured":"Taylor KD, Goel R, Stewart DJ, Wong PTT: Pressure tuning infrared spectroscopic study of cisplatin induced changes in phosphatidylserine model membrane. Proc Amer Assoc Cancer Res 33: 448, 1992","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"CR186","first-page":"440","volume":"35","author":"P Popovic","year":"1994","unstructured":"Popovic P, Wong PTT, Kates M, Grewaal D, Goel R, Molepo JM, Stewart DJ: Membrane fluidity and lipids in cisplatin resistant cells with low cisplatin uptake. Proc Am Assoc Cancer Res 35: 440, 1994","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR187","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/bi00380a038","volume":"26","author":"WJ Blitterswijk Van","year":"1987","unstructured":"Van Blitterswijk WJ, van der Meer BW, Hilkman H: Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un) saturation to membrane fluidity measured by fluorescence polarization. Biochem 26: 1746?1756, 1987","journal-title":"Biochem"},{"key":"CR188","first-page":"68","volume":"48","author":"PA Andrews","year":"1988","unstructured":"Andrews PA, Velury S, Mann SC, Howell SB: cis-Diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Research 48: 68?73, 1988","journal-title":"Cancer Research"},{"key":"CR189","first-page":"440","volume":"35","author":"DJ Stewart","year":"1994","unstructured":"Stewart DJ, Grewaal D, Popovic P, Molepo JM, Shirazi SFH, Goel R: Alteration of cisplatin uptake into lung cancer cell lines. Proc Am Assoc Cancer Res 35: 440, 1994","journal-title":"Proc Am Assoc Cancer Res"},{"issue":"30","key":"CR190","doi-asserted-by":"crossref","first-page":"21425","DOI":"10.1016\/S0021-9258(19)36627-X","volume":"267","author":"BK Lathrop","year":"1992","unstructured":"Lathrop BK, Biltonen RL: Calcium and magnesium dependence of phospholipase A2-catalyzed hydrolysis of phosphatidylcholine small unilamellar vesicles. J Biol Chem 267 (30): 21425?21431, 1992","journal-title":"J Biol Chem"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01052723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01052723\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01052723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T12:52:22Z","timestamp":1625403142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01052723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":190,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF01052723"],"URL":"https:\/\/doi.org\/10.1007\/bf01052723","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}